Article Details
Retrieved on: 2022-08-22 08:34:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
DCGI approves AstraZeneca's Lynparza for adjuvant treatment of patients with high-risk early breast cancer. New data from Olympia phase-III trial ...
Article found on: www.expresspharma.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here